Capsule with needles can deliver drugs directly into stomach lining
the ONA take:
According to a new study published in the Journal of Pharmaceutical Sciences, researchers at Massachusetts Institute of Technology in Cambridge, Massachusetts, and Massachusetts General Hospital in Boston, Massachusetts, have developed a novel drug delivery system that involves a drug capsule coated with small needles that inject the drug directly into the lining of the stomach after being swallowed.
In the study, the researchers put insulin in the capsule and tested the delivery system in animal models. They found that the capsule delivered insulin more efficiently than a subcutaneous injection. They also did not observe any adverse effects caused by the capsule passing through the digestive tract.
The researchers suggest that this method could be used instead of an intravenous infusion or subcutaneous injection of a drug. Despite only studying insulin with the delivery system, the researchers believe that it may also be useful for delivering antibodies used to treat cancer and other diseases. Because antibodies are large proteins, they are nonabsorbable and are inactivated by enzymes in the gastrointestinal tract.
The researchers are continuing to develop the device so that the digestive tract squeezes the drug out of the capsule and the capsule disintegrates to minimize safety concerns.
A novel drug delivery system that involves a drug capsule coated with small needles.
Given a choice, most patients would prefer to take a drug orally instead of getting an injection. Unfortunately, many drugs, especially those made from large proteins, cannot be given as a pill because they get broken down in the stomach before they can be absorbed. A schematic drawing of a microneedle pill with hollow needles.
To help overcome that obstacle, researchers at MIT and Massachusetts General Hospital (MGH) have devised a novel drug capsule coated with tiny needles that can inject drugs directly into the lining of the stomach after the capsule is swallowed. In animal studies, the team found that the capsule delivered insulin more efficiently than injection under the skin, and there were no harmful side effects as the capsule passed through the digestive system.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|